3,000
Participants
Start Date
April 1, 2021
Primary Completion Date
March 30, 2040
Study Completion Date
April 30, 2045
Atezolizumab
drugs used outside indication, based on biomarker
RECRUITING
St Olavs Hospital, Trondheim
NOT_YET_RECRUITING
Sykehuset Ålesund, Ålesund
RECRUITING
Haukeland universitetssykehus, Bergen
RECRUITING
Nordlandssykehuset, Bodø
RECRUITING
Vestre Viken Hospital, Drammen
RECRUITING
Førde Hospital, Førde
RECRUITING
Sykehuset Innlandet, Hamar
NOT_YET_RECRUITING
Helse Fonna, Haugesund
RECRUITING
Sørlandet sykehus, Kristiansand
NOT_YET_RECRUITING
Sykehuset Levanger, Levanger
RECRUITING
Ahus, Oslo
RECRUITING
Sykehuset Telemark, Skien
RECRUITING
Stavanger universitetssykehus, Stavanger
RECRUITING
Universitetssykehuset i Nord-Norge, Tromsø
NOT_YET_RECRUITING
Sykehuset Vestfold, Tønsberg
RECRUITING
Sykehuset Østfold Kalnes, Fredrikstad
RECRUITING
Oslo University Hospital, Oslo
Haukeland University Hospital
OTHER
St. Olavs Hospital
OTHER
University Hospital of North Norway
OTHER
University Hospital, Akershus
OTHER
Vestre Viken Hospital Trust
OTHER
Hospital of Southern Norway Trust
OTHER
Ostfold Hospital Trust
OTHER
The Hospital of Vestfold
OTHER
Helse Stavanger HF
OTHER_GOV
Nordlandssykehuset HF
OTHER
Sykehuset Innlandet HF
OTHER
Helse Forde
OTHER
Helse Fonna
OTHER
Helse Nord-Trøndelag HF
OTHER
Helse Møre og Romsdal HF
OTHER_GOV
Sykehuset Telemark
OTHER_GOV
Lovisenberg Diakonale Hospital
OTHER
Oslo University Hospital
OTHER